ea0089t9 | Trials In Progress | NANETS2022
D Puranik Ameya
, Rangarajan Venkatesh
, Ramaswamy Anant
, Ostwal Vikas
, V Shrikhande Shailesh
, Bhandare Manish
, Chaudhari Vikram
, M Bal Munita
, Agrawal Archi
, C Purandare Nilendu
, Shah Sneha
Background: Well-differentiated GEP NETs show positive uptake on Ga-68-DOTATOC PET/CT, a somatostatin-receptor (SSTR)-specific imaging tracer. 18F-FDG PET/CT is preferred for aggressive, high-grade NETs as GLUT (glucose-transporter) receptor expression entails poorer prognosis. Grade 2 NET may demonstrate heterogenous uptake of both tracers; suggestive of tumor heterogeneity. PRRT is widely available at reasonable cost since Lu-177-DOTATATE is manufactured indegenously, and is...